Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Niagen Bioscience (NASDAQ: NAGE ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Niagen Bioscience Inc. reported
1-800-Flowers.com said fiscal 2026 revenue fell 10.8% to $1.5 billion, while fourth-quarter revenue declined 12.9% to $293.1 million. The company also announced an amended credit facility and set fiscal 2027 guidance for a mid-single-digit revenue decline and adjusted EBITDA of $10 to $15 million.
Netskope reported Q2 fiscal 2027 revenue of $221 million, up 29% year over year and ahead of guidance, with ARR at $899 million, up 27% year over year.
Amazon expands same-day delivery to over 3100 US cities